title: Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy.
abstract: OBJECTIVE
  To evaluate the feasibility of sentinel node staging for detection of occult regional lymph node metastasis in high-risk cutaneous nonmelanoma malignancies.
  
  
  METHODS
  Consecutive clinical case series.
  
  
  METHODS
  Referral university medical center.
  
  
  METHODS
  A consecutive sample of patients with a variety of high-risk nonmelanoma cutaneous malignancies without evidence of regional lymph node metastases.
  
  
  METHODS
  Sentinel node biopsies were performed using preoperative lymphoscintigraphy, blue dye, and intraoperative radiolocalization.
  
  
  METHODS
  Sensitivity, determined by comparing the results of biopsy specimen evaluation with those of completion lymphadenectomy and/or clinical follow-up.
  
  
  RESULTS
  Twenty-four patients underwent sentinel node biopsy for the staging of 29 nodal basins identified by lymphoscintigraphy. Primary diagnoses were squamous cell carcinoma (n = 17), Merkel cell carcinoma (n = 5), and adenocarcinoma (n = 2). Seven patients (29%) had a tumor-positive sentinel node. Sentinel node biopsy followed by complete lymphadenectomy was performed in 12 patients and sentinel node biopsy alone in 12 patients. Tumor-positive lymph nodes were noted in 8 patients, 7 of whom also had positive sentinel nodes. There was 1 false-positive result (1/8 [12%]), in a patient with recurrent squamous cell carcinoma of the scalp. At a median follow-up of 10 months, no recurrences in a sentinel node-negative basin have been noted. Compared with all information, the sensitivity of sentinel node staging was 88% and the negative predictive value was 0.94.
  
  
  CONCLUSIONS
  Sentinel node biopsy is a minimally invasive staging procedure useful in identifying occult regional lymph node disease in selected patients with nonmelanoma cutaneous malignancies. Further studies to verify these findings and develop formal guidelines are indicated.
authors.affiliation: Division of Plastic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, USA. jdwagner@iupui.edu
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Wagner
authors.forename: David Z
authors.initials: DZ
authors.lastname: Evdokimow
authors.forename: Edward
authors.initials: E
authors.lastname: Weisberger
authors.forename: David
authors.initials: D
authors.lastname: Moore
authors.forename: Tsu-Yi
authors.initials: TY
authors.lastname: Chuang
authors.forename: Stacie
authors.initials: S
authors.lastname: Wenck
authors.forename: John J
authors.initials: JJ
authors.lastname: Coleman
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015266:Carcinoma, Merkel Cell / Q000473:pathology / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000556:secondary; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012307:Risk Factors; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000473:pathology*